entity

Aβ40

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Aβ40: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
0Hypotheses
1Analyses
1Outgoing
3Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Amyloid Beta 40 (Aβ40) - Biomarker

biomarker · 1357 words

Outgoing (1)

TargetRelationTypeStr
Alzheimer's diseasebiomarker_fordisease0.80

Incoming (3)

SourceRelationTypeStr
APPcausesprotein0.90
PSEN1decreasesgene0.80
Aβ42causesprotein0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why do p300/CBP inhibitors reduce both AD incidence and clinically diagnosed TBI

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The observation that salsalate and diflunisal decrease both AD and TBI incidence

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

Related Research

Hypotheses and analyses mentioning Aβ40 in their description or question text

No additional research found